NORDTREAT - The Nordic IBD treatment strategy trial

NORDTREAT is a Nordic collaborative treatment strategy trial, built on a novel biosignature, that aims to stratify newly diagnosed patients with inflammatory bowel disease (IBD) based on their future disease course and adapt the treatment accordingly.

Inclsuion of patients are ongoing at all main sites in the Nordic IBD treatment strategy trial

–  Due to the pandemic the study has been postponed more than a year, but now we’re right on track, he concludes.